AVDL beat EPS expectations by 46.71%
Nov 12, 2024, 5:35 PM
0.00%
What does AVDL do
Avadel Pharmaceuticals PLC, based in Dublin, specializes in biopharmaceuticals with 154 employees and develops medications like LUMRYZ for narcolepsy. Their drug delivery technologies include MICROPUMP, LIQUITIME, and MEDUSA.
Avadel Pharmaceuticals plc (AVDL) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Avadel Pharmaceuticals plc's actual EPS was -$0.03, beating the estimate of -$0.06 per share, resulting in a 46.71% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.